share_log

Blue Water Biotech Analyst Ratings

Blue Water Biotech Analyst Ratings

蓝水生物技术分析师评级
Benzinga ·  2023/09/13 11:59
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/13/2023 Maxim Group Downgrades Buy → Hold
04/26/2023 1145.67% HC Wainwright & Co. $7 → $9 Maintains Buy
02/01/2023 868.86% HC Wainwright & Co. → $7 Reiterates → Buy
12/09/2022 868.86% HC Wainwright & Co. → $7 Initiates Coverage On → Buy
12/08/2022 453.63% Maxim Group → $4 Initiates Coverage On → Buy
日期 上行/下行 分析公司 目标价格变动 评级变动 之前/当前的评级
09/13/2023 Maxim 集团 降级 买入 → 持有
2023 年 4 月 26 日 1145.67% HC Wainwright & Co. 7 美元 → 9 美元 维护 购买
02/01/2023 868.86% HC Wainwright & Co. → 7 美元 重申 → 购买
2022 年 9 月 12 日 868.86% HC Wainwright & Co. → 7 美元 启动覆盖范围开启 → 购买
2022 年 8 月 12 日 453.63% Maxim 集团 → 4 美元 启动覆盖范围开启 → 购买

What is the target price for Blue Water Biotech (BWV)?

蓝水生物技术(BWV)的目标价格是多少?

The latest price target for Blue Water Biotech (NASDAQ: BWV) was reported by Maxim Group on September 13, 2023. The analyst firm set a price target for $0.00 expecting BWV to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

Maxim集团于2023年9月13日公布了蓝水生物技术(纳斯达克股票代码:BWV)的最新目标股价。该分析公司将目标股价定为0.00美元,预计BWV将在12个月内跌至-100.00%(可能下跌-100.00%)。去年有5家分析公司公布了评级。

What is the most recent analyst rating for Blue Water Biotech (BWV)?

Blue Water Biotech(BWV)的最新分析师评级是多少?

The latest analyst rating for Blue Water Biotech (NASDAQ: BWV) was provided by Maxim Group, and Blue Water Biotech downgraded their hold rating.

蓝水生物科技(纳斯达克股票代码:BWV)的最新分析师评级由Maxim集团提供,蓝水生物技术公司下调了持仓评级。

When is the next analyst rating going to be posted or updated for Blue Water Biotech (BWV)?

Blue Water Biotech(BWV)的下一份分析师评级何时发布或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Blue Water Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Blue Water Biotech was filed on September 13, 2023 so you should expect the next rating to be made available sometime around September 13, 2024.

分析师在进行了广泛的研究后得出了股票评级,包括阅读公开财务报表、与蓝水生物技术公司的高管和客户交谈以及听取财报电话会议。大多数分析师每三个月进行一次评级,因此每家公司每年应获得4个评级。Blue Water Biotech的最新评级是在2023年9月13日提交的,因此你应该预计下一个评级将在2024年9月13日左右公布。

Is the Analyst Rating Blue Water Biotech (BWV) correct?

分析师对蓝水生物技术(BWV)的评级是否正确?

While ratings are subjective and will change, the latest Blue Water Biotech (BWV) rating was a downgraded with a price target of $0.00 to $0.00. The current price Blue Water Biotech (BWV) is trading at is $0.72, which is out of the analyst's predicted range.

尽管评级是主观的,并且会发生变化,但最新的蓝水生物技术(BWV)评级被下调,目标股价为0.00美元至0.00美元。蓝水生物技术(BWV)的当前交易价格为0.72美元,超出了分析师的预测区间。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发